If you haven't found adequate relief after trying two or more antidepressants, you may be experiencing treatment-resistant depression (TRD). This may mean that a different treatment approach is worth considering, and other treatment options may be available. Our team can review your treatment history, symptoms, and clinical needs to determine whether Spravato may be an appropriate treatment option.
Spravato (esketamine) is a prescription treatment that may be considered for certain adults with treatment-resistant depression.
Unlike traditional oral antidepressants, Spravato is a nasal spray used in a clinical setting under the supervision of a healthcare provider. A Helios provider can explain how Spravato works, review safety considerations, and determine whether it may fit your treatment plan.
Spravato treatment begins with a clinical evaluation. During this evaluation, your provider will review your depression symptoms, medication history, previous treatment response, medical history, and safety considerations.
If Spravato is appropriate, your care team will explain the treatment process, appointment expectations, monitoring requirements, and follow-up care. Spravato is used in a healthcare setting under medical supervision and is not taken home for unsupervised use.
Helios Psychiatry and Counseling offers Spravato evaluation and treatment services for eligible patients. We serve patients from Troy, Chesterfield, and surrounding Michigan communities.
Troy Office
625 E. Big Beaver Road, Suite 200
Troy, MI 48083
Chesterfield Office
30472 23 Mile Road
Chesterfield, MI 48047
Phone: (586) 863-4000
Fax: (586) 863-4004
Patients and referring providers can review our Spravato information sheet for a simple overview of the treatment and who it may be used to help.
Helios also provides psychiatric evaluations, medication management, therapy, counseling, ADHD testing, TMS treatment, and other mental health services.
Spravato is different from traditional oral antidepressants. It is a prescription nasal spray treatment that may be considered for eligible adults with treatment-resistant depression after clinical review.
Spravato may be considered for adults who have tried two or more oral antidepressants and still experience symptoms of depression. A provider must review your history and determine whether it is clinically appropriate.
No. Spravato requires clinical evaluation and treatment planning. Your provider will review your symptoms, medication history, safety considerations, and treatment goals.
Helios accepts community referrals for Spravato evaluation. Referring providers and patients can contact our office for more information about the referral process.
Helios serves patients from Troy, Chesterfield, Macomb County, Oakland County, and surrounding Michigan communities. Please contact our office to confirm appointment availability.
This page is for general educational information only and is not a substitute for medical advice, diagnosis, or treatment. Spravato is not appropriate for everyone. A qualified provider must evaluate whether Spravato is appropriate based on your symptoms, treatment history, medical history, and safety considerations.
If you are experiencing a medical emergency or are in immediate danger, call 911 or go to the nearest emergency room.